FCA
NVO

FLC Capital Advisors’s Novo Nordisk NVO Stock Holding History

FLC Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Sell
9,824
-800
-8% -$34.4K 0.08% 140
2026
Q1 		$390K Buy
+10,624
New +$503K 0.07% 149
2025
Q1 		– Sell
-2,750
Closed -$237K – 188
2024
Q4 		$237K Hold
2,750
– – 0.05% 157
2024
Q3 		$327K Hold
2,750
– – 0.08% 129
2024
Q2 		$393K Hold
2,750
– – 0.1% 110
2024
Q1 		$353K Hold
2,750
– – 0.09% 114
2023
Q4 		$284K Hold
2,750
– – 0.08% 124
2023
Q3 		$250K Hold
2,750
– – 0.08% 126
2023
Q2 		$223K Hold
2,750
– – 0.07% 138
2023
Q1 		$219K Buy
+2,750
New +$195K 0.07% 148

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

FLC Capital Advisors's NVO Position: Q2 2026 in Review

FLC Capital Advisors reduced its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, selling an estimated $34.4K and leaving 9,824 shares worth $471K. The position accounts for 0.08% of the portfolio, ranked #140.

FLC Capital Advisors first reported a position in NVO in Q1 2023 and has held it in 10 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • FLC Capital Advisors held 9,824 shares of Novo Nordisk worth $471K as of Q2 2026.
  • FLC Capital Advisors sold 800 Novo Nordisk shares in Q2 2026, an estimated $34.4K.
  • Novo Nordisk made up 0.08% of FLC Capital Advisors's portfolio in Q2 2026, its #140 holding.
  • FLC Capital Advisors first reported a position in Novo Nordisk in Q1 2023 and has held it in 10 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.